Mumm-Ra's Dark Bargain for Immortality Drives ThunderCats-SilverHawks Crossover Comic
By
Mr Bagel
Dynamite Entertainment's ThunderCats x SilverHawks crossover event takes a sinister turn with the release of Mumm-Ra The Ever-Living 4, a tie-in that zeroes in on the franchise's iconic villain. According to Comic Book Addicts, the issue returns readers to the place where the ancient sorcerer is most dangerous: isolated, wounded, and desperate. Meanwhile, Bleeding Cool previewed the comic, highlighting a dark bargain that could grant Mumm-Ra true immortality.
"Mumm-Ra The Ever-Living 4 brings the ThunderCats x SilverHawks event tie-in back to the place where Mumm-Ra is most dangerous: alone, abandoned, wounded, and ready …"
That description frames the issue not as a sprawling crossover spectacle but as a focused character study, stripping away allies and distractions to emphasize the raw threat of a cornered villain. The review suggests the story makes evil feel ancient again, tapping into the character's supernatural roots rather than relying on the usual cat-and-bird team-ups.
"the villain Mumm-Ra making a dark bargain to achieve true immortality"
The preview from Bleeding Cool confirms that Mumm-Ra's quest for eternal life is the engine of the plot. The bargain itself remains shrouded, but the stakes are clear: if Mumm-Ra succeeds, he could become an unkillable force in the crossover saga. Both outlets agree that this issue deepens the crossover's mythology by centering one of the most enduring threats in the ThunderCats universe.
Comic Book Addicts praised the issue for focusing on Mumm-Ra's loneliness and desperation, while Bleeding Cool's preview teased the narrative payoff of his immortality gambit. Together, the coverage positions Mumm-Ra The Ever-Living 4 as a key chapter that enriches the larger crossover, proving that even in a story uniting two franchises, the most compelling drama often belongs to the villain.
The reporting
2 outlets covered this story. Each links to the original.
Baker's Take

Comments
Sign in to join the conversation.
No comments yet. Be the first.